IE37596B1 - 21-substituted 3alpha-hydroxy pregnanes - Google Patents

21-substituted 3alpha-hydroxy pregnanes

Info

Publication number
IE37596B1
IE37596B1 IE709/73A IE70973A IE37596B1 IE 37596 B1 IE37596 B1 IE 37596B1 IE 709/73 A IE709/73 A IE 709/73A IE 70973 A IE70973 A IE 70973A IE 37596 B1 IE37596 B1 IE 37596B1
Authority
IE
Ireland
Prior art keywords
alpha
substituted
3alpha
hydroxy
additionally
Prior art date
Application number
IE709/73A
Other languages
English (en)
Other versions
IE37596L (en
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of IE37596L publication Critical patent/IE37596L/xx
Publication of IE37596B1 publication Critical patent/IE37596B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
IE709/73A 1972-05-05 1973-05-04 21-substituted 3alpha-hydroxy pregnanes IE37596B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2114272A GB1430942A (en) 1972-05-05 1972-05-05 21-substituted 3alpha-hydroxy pregnanes

Publications (2)

Publication Number Publication Date
IE37596L IE37596L (en) 1973-11-05
IE37596B1 true IE37596B1 (en) 1977-08-31

Family

ID=10157915

Family Applications (1)

Application Number Title Priority Date Filing Date
IE709/73A IE37596B1 (en) 1972-05-05 1973-05-04 21-substituted 3alpha-hydroxy pregnanes

Country Status (16)

Country Link
JP (1) JPS4961150A (en:Method)
AT (1) AT355232B (en:Method)
AU (1) AU475168B2 (en:Method)
BE (1) BE799102A (en:Method)
CA (1) CA1013341A (en:Method)
CH (1) CH617710A5 (en:Method)
DE (1) DE2322532A1 (en:Method)
ES (1) ES414411A1 (en:Method)
FR (1) FR2183792B1 (en:Method)
GB (1) GB1430942A (en:Method)
IE (1) IE37596B1 (en:Method)
IL (1) IL42196A (en:Method)
LU (1) LU67546A1 (en:Method)
NL (1) NL7306234A (en:Method)
SE (1) SE400771B (en:Method)
ZA (1) ZA733035B (en:Method)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
ES2296594T3 (es) * 1994-02-14 2008-05-01 Euro-Celtique S.A. Androstanos y pregnanos para la modulacion alosterica del receptor de gaba.
US5939545A (en) 1994-02-14 1999-08-17 Cocensys, Inc. Method, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series
GR1003861B (el) * 2000-12-29 2002-04-11 Νεα νευροστεροειδη που αλληλεπιδρουν με τον υποδοχεα gabaa.
JP4915427B2 (ja) * 2009-03-30 2012-04-11 ブラザー工業株式会社 液体供給ジョイント、これを使用した液体吐出ヘッド及び記録装置
CN104136452A (zh) 2011-10-14 2014-11-05 萨奇治疗股份有限公司 3,3-二取代的19-去甲孕甾烷化合物、组合物、及其用途
RU2681835C2 (ru) 2012-01-23 2019-03-13 Сейдж Терапьютикс, Инк. Лекарственные формы нейроактивных стероидов и способы лечения нарушений цнс
AU2013305767B2 (en) 2012-08-21 2018-05-24 Sage Therapeutics, Inc. Methods of treating epilepsy or status epilepticus
LT2986624T (lt) 2013-04-17 2020-07-10 Sage Therapeutics, Inc. Neuroaktyvūs 9-nor steroidai, skirti gydymo metodams
US20160068563A1 (en) 2013-04-17 2016-03-10 Boyd L. Harrison 19-nor neuroactive steroids and methods of use thereof
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
PL3498725T3 (pl) 2013-04-17 2021-11-08 Sage Therapeutics, Inc. 19-Nor C3,3-dipodstawiony C21-N-pirazolilo-steroid do zastosowania w terapii
RS61733B1 (sr) 2013-07-19 2021-05-31 Sage Therapeutics Inc Neuroaktivni steroidi, njihove kompozicije i upotrebe
WO2015027227A1 (en) 2013-08-23 2015-02-26 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
JOP20200195A1 (ar) 2014-09-08 2017-06-16 Sage Therapeutics Inc سترويدات وتركيبات نشطة عصبياً، واستخداماتها
RS60642B1 (sr) 2014-10-16 2020-09-30 Sage Therapeutics Inc Kompozicije i postupci za lečenje poremećaja cns-a
CN117024502A (zh) 2014-10-16 2023-11-10 萨奇治疗股份有限公司 靶向cns障碍的组合物和方法
JP6893173B2 (ja) 2014-11-27 2021-06-23 セージ セラピューティクス, インコーポレイテッド Cns障害を処置するための組成物および方法
PT3250210T (pt) 2015-01-26 2021-03-26 Sage Therapeutics Inc Composições e métodos para o tratamento de distúrbios do snc
DK3258939T3 (da) 2015-02-20 2022-12-12 Sage Therapeutics Inc Neuroaktive steroider, sammensætninger og anvendelser heraf
US20200306265A1 (en) 2016-03-08 2020-10-01 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
MA45599A (fr) 2016-07-11 2019-05-15 Sage Therapeutics Inc Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation
JP7065825B2 (ja) 2016-07-11 2022-05-12 セージ セラピューティクス, インコーポレイテッド C7、c12、およびc16置換神経刺激性ステロイドおよびそれらの使用方法
WO2020243488A1 (en) 2019-05-31 2020-12-03 Sage Therapeutics, Inc. Neuroactive steroids and compositions thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1346292A (fr) * 1962-09-14 1963-12-20 Roussel Uclaf Nouveau procédé de préparation des 21-amino stéroïdes
US3144446A (en) * 1963-12-20 1964-08-11 Upjohn Co Mono and bis nu-(3alpha, 17alpha-dihydroxy-11, 20-dioxo-5beta-pregnan-21-yl) quaternary ammonium salts of triethylenediamine

Also Published As

Publication number Publication date
ATA395173A (de) 1979-07-15
BE799102A (fr) 1973-11-05
FR2183792B1 (en:Method) 1977-07-15
GB1430942A (en) 1976-04-07
CH617710A5 (en) 1980-06-13
AT355232B (de) 1980-02-25
IL42196A (en) 1978-10-31
AU5528473A (en) 1974-11-07
JPS4961150A (en:Method) 1974-06-13
IE37596L (en) 1973-11-05
SE400771B (sv) 1978-04-10
NL7306234A (en:Method) 1973-11-07
FR2183792A1 (en:Method) 1973-12-21
AU475168B2 (en) 1976-08-12
ZA733035B (en) 1974-04-24
CA1013341A (en) 1977-07-05
IL42196A0 (en) 1973-07-30
DE2322532A1 (de) 1973-11-22
LU67546A1 (en:Method) 1973-07-13
ES414411A1 (es) 1976-02-01

Similar Documents

Publication Publication Date Title
IE37596L (en) 21-substituted 3ó-hydroxy pregnanes.
IE38617L (en) 11, 11-alkylidene steroids.
GB1418003A (en) Fasteners
CA1016535A (en) .delta. 8,9 steroids of the pregnane series
DK131474B (da) Analogifremgangsmåde til fremstilling af 9alfa-halogen-11beta, 17alfa, 21-trihydroxy-16beta-metylpregna-1,4-dien-3,20-dion-21-adamantan-1'-karboxylater.
GB1187660A (en) Fluoroformates of Steroid 17-beta-Ols
AU468273B2 (en) 16, 17-cyclopropa steroids ofthe androstane series
IE37597B1 (en) 21-fluoro-pregnanes
GB1419216A (en) Oleandrin derivative
GB1182283A (en) Process for the Manufacture of 15,16beta-Methylene-Steroids
CA815065A (en) N-PROPYL-13.beta. BIS NOR-18,19 SECO-4,5 PREGNANE, PREGNENE ET PREGNADIENE
GB1131445A (en) Novel steroids
IE38899L (en) Pyridine derivatives.
NZ182865A (en) 2.9 -dichloro-6 -fluoro-16 -methyl-11 ,17 , 21-trihydroxy-pregna-1,4-diene-3,20-diones
CA859136A (en) 16-ALKYL-11-OXYGENATED-4-PREGNENE-17.alpha.-OL-3,20-DIONE AND THE CORRESPONDING 1,4-PREGNADIENE COMPOUNDS
CA969175A (en) 6.alpha.,9.alpha.-DIFLUOROSTEROIDS OF THE PREGNANE SERIES AND PROCESSES FOR THEIR MANUFACTURE
JPS51125129A (en) Cold cure adhesive compositions
IE36373B1 (en) Substituted benzimidazolecarbamates and tautomers thereof
CA857869A (en) 6.alpha.,16.beta.-DIMETHYL-11-OXYGENATED-4-PREGNENE-17.alpha.,21-DIOL-3,20-DIONES
CA700410A (en) METHOD OF PREPARING SUBSTITUTED 21-SULFONYLOXY-16.alpha.,17.alpha.-DIHYDROXY STEROIDS OF THE PREGNANE SERIES
CA684358A (en) 3-oxatricyclo (3.2.1.02,4) octane-6,7-diol and the cyclic carbonate thereof
CA880871A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 6-METHYL-16-METHYLENE-17.alpha.-HYDROXY-4,6-PREGNADIENE-3,20-DIONE 17-ACETATE
CA737447A (en) 3,6,20-TRIOXO A-NOR B-HOMO 10 .epsilon. 19-NOR PREGNANE
CA972350A (en) 1,2-METHYLENE-17.alpha.-ACYLOXY(OR IMPROVED HYDROXY)-9.beta.,10.alpha.-STEROID COMPOUNDS OF THE PREGNANE SERIES, PHARMACEUTIC PREPARATIONS OF THE BASIS OF THE NOVEL COMPOUNDS AND METHODS OF PRODUCING SAID COMPOUNDS AND PREPARATIONS
GB1285263A (en) IMPROVEMENTS IN OR RELATING TO 6alpha,6beta-DIFLUORO STEROIDS